Massimo Radaelli President & CEO presso Noventia Pharma 3d
Dear Daniel
I fully agree on this new vision adopting the hub-and-spoke model, as a very nnovative strategy involving multiple portfolio companies or subsidiaries under the same umbrella, each addressing a different area of treatment
And last but not least investing in this type of companies could come with less risk because if one area doesn't perfectly work out the way management expects, the other areas could lend the additional support required.
Thus means that addressing multiple technologies or treatment areas enables a company to attract capital from a broader range of investors
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.